Clinical Development of a Novel Vitamin K Epoxide Reductase (VKOR) Inhibitor, Tecarfarin: Results of Phase 2 Studies and Design of Phase 3 Warfarin-controlled Study
JOURNAL OF THROMBOSIS AND THROMBOLYSIS（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined